AJ

Active Director Whole-Time Director DIN 00113405
DIN 00113405 First appointment Jul 2012 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2012
Shareholding value •••• Premium profile

About Anil Jha

Data last updated:

Anil Jha is a Whole-Time Director at Orichem Drugs & Pharmaceuticals Pvt. Ltd (since 2012). The company operates in Pharma. Orichem Drugs & Pharmaceuticals Pvt. Ltd reported revenue of ₹33.03 Cr (FY 2025).

DIN 00113405
Primary Designation Whole-Time Director
Industry Pharma
First Appointment 11 Jul 2012
Oldest Company Age 40 yrs
Largest company Orichem Drugs & Pharmaceuticals Pvt. Ltd · ₹33.03 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Whole-Time Director11 Jul 20121986₹33.03 Cr (FY 2025)Active

Board colleagues of Anil Jha

Directorship timeline

Open interactive timeline →
Orichem Drugs & Pharmaceuticals Pvt. Ltd
Premium access

Shareholding and investment profile for Anil Jha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anil Jha

Anil Jha currently holds 1 directorship: Orichem Drugs & Pharmaceuticals Pvt. Ltd (Whole-Time Director, since 11 Jul 2012, revenue ₹33.03 Cr (FY 2025)).

Anil Jha was first appointed on 11 Jul 2012 as Whole-Time Director at Orichem Drugs & Pharmaceuticals Pvt. Ltd.

The current boards of Anil Jha's companies include Manjulata Jha (Orichem Drugs & Pharmaceuticals Pvt. Ltd), Navin Chandra Jha (Orichem Drugs & Pharmaceuticals Pvt. Ltd), Umesh Chandra Jha (Orichem Drugs & Pharmaceuticals Pvt. Ltd).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available